James

[James @biotechtoast]

@GMEshortsqueeze @Stocktwits @wallstreetbets @BioStocks $VKTX - Well CEO BL did his new CMO (former pet drug employee) a solid, diluted shareholders by 190k shares for nice options he gave him at $ 31.27 06/01/2026 190,000, already made 1.2 million for doing nothing, the BL way

[James @biotechtoast]

@GMEshortsqueeze @Stocktwits @wallstreetbets @BioStocks $VKTX - Have to give credit to the shorts today, they are doing their best as well to keep this thing down even though CEO does a great job of it on his own selling.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - Whoever is mass exiting this stock with these block sales yesterday heavy (now know why off Dr. Chen hire) and again has paused to let the price bounce a little, expect more throughout this afternoon. Smart

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - People saying CMO hiring is confidence, fast track, lol. This is desperation by BL hoping people would be fooled thinking great news. Quite opposite, this show no one is interested, too late for Baker Brothers even

[James @biotechtoast]

@GMEshortsqueeze @wallstreetbets @Stocktwits @BioStocks $VKTX - Well look at the bright side, CEO BL can change the name to Viking Dog Shampoo, do a reverse split, load himself with more options and might do well. Definitely would fit more mgmt experience vs biotech.

[James @biotechtoast]

@GMEshortsqueeze @Stocktwits @wallstreetbets @BioStocks $VKTX - It’s clear no reputable CCO or CMO would leave to work for VKTX, failed phase 2 pill & old Phase 3 drug. BP did not even make an offer / partner as they know, low tier CCO/CMO at least will get options before fail.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - Expect another drop today based on BL hiring, think he will be hiring clowns from the circus next, total embarrassment of a CEO. Looks like VKTX mgmt going into meeting

[James @biotechtoast]

@GMEshortsqueeze @Stocktwits @BioStocks @wallstreetbets $VKTX - BL is terrible at hiring, his CCO Neil worked for biotech ABCL, 40.00 to 5.00 during his tenure there. Now new hire Dr. Chen, worked for a company developing a drug for “dogs” 😂. BP is laughing, why stock tanked

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - How about that stock buyback CEO BL put in place, oh yeah, they don’t have cash to do it😂😂. Thought he would deter the shorts, that worked out well.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - Lilly’s retatrutide produced 25.9%–28.3% mean weight loss at week 80 in obesity, and the 4 mg dose produced 19.0% weight loss with fewer escalation steps. This is why VKTX is down and watch 3-4.. Game over.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - Impressive to see all the block sales now, they are not hiding with little ones anymore and someone just loaded up with June 12 exp 25 puts, smart.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - Volume increasing significantly looks like some possible bad news, trial halt, cap raise (they should before stock 0.00)? Has been pumped for 2 1/2 years from 90 down, if BP wanted it they would do hostile offer.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - Looks like CEO is presenting at another fireside chat and missed the other conference where the successful companies are presenting.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - look at level 2 you will see someone is exiting this and trying to hide in small blocks, would not doubt if old BL selling again to reload after his options self award.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - the stock price action is telling you, short interest telling you, the incompetent mgmt telling you, FMR and Blackrock sells telling you, no buyout offers or even partner is telling you. Heading back to all low.

[James @biotechtoast]

lol, not short just reading the facts. This CEO botched a china deal and then ends up in lawsuit, now losing mash rights, self awards options, former bank analyst has no clue what he is doing other then taking money from company for his piggy bank. Good luck there.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - 22.3 million shares short and 11.68 days to cover, so far the smart money have been right all the way down from 90.00. They don’t keep that type of gain on unless they are very confident more profit to be made.

[James @biotechtoast]

@GMEshortsqueeze @Stocktwits @BioStocks @wallstreetbets $VKTX - Will be hilarious when NVO buys GPCR, they have the peptide pill then will have small molecule as backup, that is what both stocks are trading like. Then VKTX left in the cold until run out of cash.

[James @biotechtoast]

@GMEshortsqueeze @BioStocks @Stocktwits @wallstreetbets $VKTX - LLY, GPCR, NVO all up and VKTX? Down as usual. Bad news it is making lower highs and lower lows, not bouncing back to 30s this time. CEO no where to be found. GPCR up 14% in 2 days.

[James @biotechtoast]

@GMEshortsqueeze @Stocktwits @wallstreetbets @BioStocks $VKTX - CEO BL does all these wasted fireside chats, yet he does not attend the largest diabetes conference when every BP in space attends, all on CNBC, congrats to the GPCR CEO for attending and interviews on CNBC.